Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,219

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Open access
Götzinger, Florian, Santiago-García, Begoña, Noguera-Julián, Antoni, Lanaspa, Miguel, Lancella, Laura, Calò Carducci, Francesca I, Gabrovska, Natalia, Velizarova, Svetlana, Prunk, Petra, Osterman, Veronika, Krivec, Uros, Lo Vecchio, Andrea, Shingadia, Delane, Soriano-Arandes, Antoni, Melendo, Susana, Lanari, Marcello, Pierantoni, Luca, Wagner, Noémie, L'Huillier, Arnaud G, Heininger, Ulrich, Ritz, Nicole, Bandi, Srini, Krajcar, Nina, Roglić, Srđan, Santos, Mar, Christiaens, Christelle, Creuven, Marine, Buonsenso, Danilo, Welch, Steven B, Bogyi, Matthias, Brinkmann, Folke, Tebruegge, Marc, Pfefferle, Jasmin, Zacharasiewicz, Angela, Berger, Angelika, Berger, Roland, Strenger, Volker, Kohlfürst, Daniela S., Zschocke, Anna, Bernar, Benoît, Simma, Burkhard, Haberlandt, Edda, Thir, Christina, Biebl, Ariane, Vanden Driessche, Koen, Boiy, Tine, Van Brusselen, Daan, Bael, An, Debulpaep, Sara, Schelstraete, Petra, Pavic, Ivan, Nygaard, Ulrikka, Glenthoej, Jonathan P., Heilmann Jensen, Lise, Lind, Ilona, Tistsenko, Mihhail, Uustalu, Ülle, Buchtala, Laura, Thee, Stephanie, Kobbe, Robin, Rau, Cornelius, Schwerk, Nicolaus, Barker, Michael, Tsolia, Maria, Eleftheriou, Irini, Gavin, Patrick, Kozdoba, Oksana, Zsigmond, Borbàla, Valentini, Piero, Ivaškeviciene, Inga, Ivaškevicius, Rimvydas, Vilc, Valentina, Schölvinck, Elisabeth, Rojahn, Astrid, Smyrnaios, Anastasios, Klingenberg, Claus, Carvalho, Isabel, Ribeiro, Andreia, Starshinova, Anna, Solovic, Ivan, Falcón, Lola, Neth, Olaf, Minguell, Laura, Bustillo, Matilde, Gutiérrez-Sánchez, Aida M., Guarch Ibáñez, Borja, Ripoll, Francesc, Soto, Beatriz, Kötz, Karsten, Zimmermann, Petra, Schmid, Hanna, Zucol, Franziska, Niederer, Anita, Buettcher, Michael, Cetin, Benhur S., Bilogortseva, Olga, Chechenyeva, Vera, Demirjian, Alicia, Shackley, Fiona, McFetridge, Lynne, Speirs, Lynne, Doherty, Conor, Jones, Laura, McMaster, Paddy, Murray, Clare, Child, Frances, Beuvink, Yvonne, Makwana, Nick, Whittaker, Elisabeth, Williams, Amanda, Fidler, Katy, Bernatoniene, Jolanta, Song, Rinn, Oliver, Zoe, Riordan, Andrew·2020·The Lancet Child & Adolescent Health

Abstract

Background To date, few data on paediatric COVID-19 have been published, and most reports originate from China. This study aimed to capture key data on children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across Europe to inform physicians and health-care service planning during the ongoing pandemic. Methods This multicentre cohort study involved 82 participating health-care institutions across 25 European countries, using a well established research network—the Paediatric Tuberculosis Network European Trials Group (ptbnet)—that mainly comprises paediatric infectious diseases specialists and paediatric pulmonologists. We included all individuals aged 18 years or younger with confirmed SARS-CoV-2 infection, detected at any anatomical site by RT-PCR, between April 1 and April 24, 2020, during the initial peak of the European COVID-19 pandemic. We explored factors associated with need for intensive care unit (ICU) admission and initiation of drug treatment for COVID-19 using univariable analysis, and applied multivariable logistic regression with backwards stepwise analysis to further explore those factors significantly associated with ICU admission. Findings 582 individuals with PCR-confirmed SARS-CoV-2 infection were included, with a median age of 5·0 years (IQR 0·5–12·0) and a sex ratio of 1·15 males per female. 145 (25%) had pre-existing medical conditions. 363 (62%) individuals were admitted to hospital. 48 (8%) individuals required ICU admission, 25 (4%) mechanical ventilation (median duration 7 days, IQR 2–11, range 1–34), 19 (3%) inotropic support, and one (<1%) extracorporeal membrane oxygenation. Significant risk factors for requiring ICU admission in multivariable analyses were being younger than 1 month (odds ratio 5·06, 95% CI 1·72–14·87; p=0·0035), male sex (2·12, 1·06–4·21; p=0·033), pre-existing medical conditions (3·27, 1·67–6·42; p=0·0015), and presence of lower respiratory tract infection signs or symptoms at presentation (10·46, 5·16–21·23; p<0·0001). The most frequently used drug with antiviral activity was hydroxychloroquine (40 [7%] patients), followed by remdesivir (17 [3%] patients), lopinavir–ritonavir (six [1%] patients), and oseltamivir (three [1%] patients). Immunomodulatory medication used included corticosteroids (22 [4%] patients), intravenous immunoglobulin (seven [1%] patients), tocilizumab (four [1%] patients), anakinra (three [1%] patients), and siltuximab (one [<1%] patient). Four children died (case-fatality rate 0·69%, 95% CI 0·20–1·82); at study end, the remaining 578 were alive and only 25 (4%) were still symptomatic or requiring respiratory support. Interpretation COVID-19 is generally a mild disease in children, including infants. However, a small proportion develop severe disease requiring ICU admission and prolonged ventilation, although fatal outcome is overall rare. The data also reflect the current uncertainties regarding specific treatment options, highlighting that additional data on antiviral and immunomodulatory drugs are urgently needed. Funding ptbnet is supported by Deutsche Gesellschaft für Internationale Zusammenarbeit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-4642(20)30177-2

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 1,219

Metadata

Authors
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Calò Carducci, F. I., Gabrovska, N., Velizarova, S., Prunk, P., Osterman, V., Krivec, U., Lo Vecchio, A., Shingadia, D., Soriano-Arandes, A., Melendo, S., Lanari, M., Pierantoni, L., Wagner, N., L'Huillier, A. G., Heininger, U., Ritz, N., Bandi, S., Krajcar, N., Roglić, S., Santos, M., Christiaens, C., Creuven, M., Buonsenso, D., Welch, S. B., Bogyi, M., Brinkmann, F., Tebruegge, M., Pfefferle, J., Zacharasiewicz, A., Berger, A., Berger, R., Strenger, V., Kohlfürst, D. S., Zschocke, A., Bernar, B., Simma, B., Haberlandt, E., Thir, C., Biebl, A., Vanden Driessche, K., Boiy, T., Van Brusselen, D., Bael, A., Debulpaep, S., Schelstraete, P., Pavic, I., Nygaard, U., Glenthoej, J. P., Heilmann Jensen, L., Lind, I., Tistsenko, M., Uustalu, Ü., Buchtala, L., Thee, S., Kobbe, R., Rau, C., Schwerk, N., Barker, M., Tsolia, M., Eleftheriou, I., Gavin, P., Kozdoba, O., Zsigmond, B., Valentini, P., Ivaškeviciene, I., Ivaškevicius, R., Vilc, V., Schölvinck, E., Rojahn, A., Smyrnaios, A., Klingenberg, C., Carvalho, I., Ribeiro, A., Starshinova, A., Solovic, I., Falcón, L., Neth, O., Minguell, L., Bustillo, M., Gutiérrez-Sánchez, A. M., Guarch Ibáñez, B., Ripoll, F., Soto, B., Kötz, K., Zimmermann, P., Schmid, H., Zucol, F., Niederer, A., Buettcher, M., Cetin, B. S., Bilogortseva, O., Chechenyeva, V., Demirjian, A., Shackley, F., McFetridge, L., Speirs, L., Doherty, C., Jones, L., McMaster, P., Murray, C., Child, F., Beuvink, Y., Makwana, N., Whittaker, E., Williams, A., Fidler, K., Bernatoniene, J., Song, R., Oliver, Z., & Riordan, A.
Venue
The Lancet Child & Adolescent Health
Publisher
Elsevier BV
Published
2020-09
Volume
4
Issue
9
Pages
653-661
ISSN
2352-4642 (ISSN-L)
OpenAlex
W3037183278
Cited by
1,219
References
3
FWCI
31.90
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. https://app.cochat.ai/papers/10.1016/s2352-4642(20)30177-2
The paper
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Calò Carducci, F. I., Gabrovska, N., Velizarova, S., Prunk, P., Osterman, V., Krivec, U., Lo Vecchio, A., Shingadia, D., Soriano-Arandes, A., Melendo, S., Lanari, M., Pierantoni, L., Wagner, N., L'Huillier, A. G., . . . Riordan, A. (2020). COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(20)30177-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.